Loading...

News

Arkstone Medical Solutions and Dendi Announce Strategic Partnership

Arkstone Medical Solutions and Dendi Announce Strategic Partnership

The partnership between Arkstone Medical Solutions and Dendi represents a significant step forward in providing healthcare providers with the tools and technologies they need to make informed clinical decisions.
Read More
Arkstone’s Treatment Recommendations Now Include Realtime National Institutes of Health (NIH) Data

Arkstone’s Treatment Recommendations Now Include Realtime National Institutes of Health (NIH) Data

The NIH has been collecting lab result isolate data for decades, compiling information about the prevalence of antimicrobial resistance genes in specific organisms.
Read More
Arkstone’s OneChoice Treatment Recommendations Now Include Renal and Hepatic Reference Adjustments

Arkstone’s OneChoice Treatment Recommendations Now Include Renal and Hepatic Reference Adjustments

Now, providers have access to detailed and dynamic renal and hepatic dosing adjustments for any treatment recommendations provided.
Read More
Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Many healthcare providers treating infections in a pregnant patient have difficulty finding the best treatment, while also taking into consideration an antimicrobial that will have the lowest risk to the fetus.
Read More
Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Ovation LIMS/LIS enables prominent molecular diagnostic laboratories to provide comprehensive test results to thousands of clinicians nationwide. Now, these labs can deliver the Arkstone OneChoice report combined with the patient’s detected pathogens and antibiotic resistance genes outlined in the infectious disease laboratory results.
Read More
Arkstone’s Launches Revolutionary MedsMatrix

Arkstone’s Launches Revolutionary MedsMatrix

MedsMatrix expands on OneChoice by giving the provider a clear understanding of what different treatment options are, and even some insight into how the OneChoice decision engine came to its conclusions
Read More
Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics

Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics

Dr. Juan Carlos Gómez de la Torre Pretell, founder of the Peruvian Institute of Molecular Biology, will be an integral part of Arkstone’s advancements in the use of artificial intelligence to democratize infectious disease expertise and increase antibiotic stewardship.
Read More
Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program

Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program

The Antimicrobial Stewardship Monthly Report includes month-to-month tracking of infections from many different sources, including respiratory, wound, urine, and GI. The report breaks down the most common types of infections and resistance genes and analyzes this data so that trends are easily visible, allowing for the implementation of proactive surveillance and infection control policies.
Read More